Functional Analysis of a De Novo Monoallelic NEK8 Variant Supports Pathogenicity for a Polycystic Kidney Disease Phenotype
Whitney S. Thompson(Mayo Clinic), Christian Hanna(Mayo Clinic), Theodora A. Potretzke(Mayo Clinic), Kun Ling(Peking University), Hana Yang(Mayo Clinic), Chuan Chen(Mayo Clinic), Peter C. Harris(Mayo Clinic), Carl H. Cramer(Mayo Clinic), Sara Hassan(Mayo Clinic)
Cited by 1
Related Papers
Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis.
|The Journal of Experimental Medicine|1984|483
Mutations in GANAB , Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease
|The American Journal of Human Genetics|2016|463
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca <sup>2+</sup> -permeable nonselective cation channel
|Proceedings of the National Academy of Sciences|2000|447
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
|Journal of Clinical Investigation|2012|444
Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease
|The American Journal of Human Genetics|2018|310